Genmab AS Stock Quote GE9 - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

181.60

Bid

180.60

Ask

182.55

Volume

269

182.20 Day's Range 187.20

174.85 52 Week Range 285.30

Market Cap

11.93B

Previous Close

187.05

Open

187.20

Last Trade

182.2

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

574

Shares Outstanding

65,691,573

Dividend Yield

PE Ratio

1.65

Earnings Per Share (EPS)

119.41

Revenue

21.53B

Net Profit

7.84B

Sector

Biological Pds,ex Diagnstics

Industry

Biogenetic (human)

Website

www.genmab.com

Headquarters

Copenhagen, Dnk

Founded

2000

Genmab AS is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GE9. The last closing price for Genmab AS was 187.05 €. Over the last year, Genmab AS shares have traded in a share price range of 174.85 € to 285.30 €.

Genmab AS currently has 65,691,573 shares outstanding. The market capitalization of Genmab AS is 12.29 € billion. Genmab AS has a price to earnings ratio (PE ratio) of 1.65.

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer...

Genmab Announces Initiation of Share Buy-Back Program

Genmab Announces Initiation of Share Buy-Back Program Company Announcement Repurchase of up to 2.2 million shares with a maximum aggregate total...

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. Company Announcement AbbVie Inc. files complaint...

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer Media...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company...

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to...

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38 Company Announcement Johnson & Johnson has decided that it will not...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company...

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab Company Announcement COPENHAGEN...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.95	-0.520405368392	182.55	188.05	174.85	452	179.28591674	DE
4	-35.8	-16.4673413063	217.4	223.8	174.85	701	195.18081918	DE
12	-23.9	-11.6301703163	205.5	223.8	174.85	574	197.84279718	DE
26	-38.3	-17.4170077308	219.9	223.8	174.85	454	201.18429549	DE
52	-98.9	-35.2584670232	280.5	285.3	174.85	321	215.76074125	DE
156	-139.1	-43.3738696601	320.7	362.9	174.85	253	229.49333269	DE
260	-192	-51.391862955	373.6	374.3	174.85	215	229.97065212	DE

GE9 - Frequently Asked Questions (FAQ)

What is the current Genmab AS share price?

The current share price of Genmab AS is 181.60 €

How many Genmab AS shares are in issue?

Genmab AS has 65,691,573 shares in issue

What is the market cap of Genmab AS?

The market capitalisation of Genmab AS is EUR 12.29B

What is the 1 year trading range for Genmab AS share price?

Genmab AS has traded in the range of 174.85 € to 285.30 € during the past year

What is the PE ratio of Genmab AS?

The price to earnings ratio of Genmab AS is 1.65

What is the cash to sales ratio of Genmab AS?

The cash to sales ratio of Genmab AS is 0.6

What is the reporting currency for Genmab AS?

Genmab AS reports financial results in DKK

What is the latest annual turnover for Genmab AS?

The latest annual turnover of Genmab AS is DKK 21.53B

What is the latest annual profit for Genmab AS?

The latest annual profit of Genmab AS is DKK 7.84B

What is the registered address of Genmab AS?

The registered address for Genmab AS is KALVEBOD BRYGGE 43, COPENHAGEN, 1260

What is the Genmab AS website address?

The website address for Genmab AS is www.genmab.com

Which industry sector does Genmab AS operate in?

Genmab AS operates in the BIOGENETIC (HUMAN) sector

Symbol	Price	Vol.
LX31Lexicon Pharmaceuticals Inc	0.5745 € (79.98%)	329.4k
AMIMedondo Holding AG	0.45 € (73.08%)	3.1k
CK1RAREX LTD	0.018 € (50.00%)	32.7k
DBVDBV Technologies	1.114 € (42.82%)	108.08k
OL11Euro Sun Mining Inc	0.0678 € (34.52%)	191.06k
MDG1Medigene AG	0.75 € (-51.52%)	40.73k
CR6AWolfspeed Inc	2.50 € (-50.10%)	969.3k
VOPInvestigator Resources Ltd	0.0115 € (-34.29%)	3.94k
EJ7Energy Resources of Australia	0.001 € (-33.33%)	86.2k
E7TAlexium International Group Share	0.0045 € (-30.77%)	34.05k
FMKEcograf Limited	0.1565 € (-13.77%)	9.14M
PF8European Lithium Limited	0.022 € (-8.33%)	5.3M
D7GNel ASA	0.2149 € (-5.16%)	4.26M
3CPXiaomi Corporation	5.871 € (-4.46%)	3.03M
DMJDynaCERT Inc	0.113 € (-6.61%)	2.02M

Symbol

Price

Vol.

FMKEcograf Limited

0.1565 €

(-13.77%)

9.14M

PF8European Lithium Limited

0.022 €

(-8.33%)

5.3M

D7GNel ASA

0.2149 €

(-5.16%)

4.26M

3CPXiaomi Corporation

5.871 €

(-4.46%)

3.03M

DMJDynaCERT Inc

0.113 €

(-6.61%)

2.02M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genmab AS (GE9)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Genmab AS

Ask ADVFN Intelligence (AI)

GE9 Latest News

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

Genmab Announces Initiation of Share Buy-Back Program

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

GE9 - Frequently Asked Questions (FAQ)

Movers

GE9 Financials

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genmab AS (GE9) Quote

Genmab AS (GE9)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Genmab AS

Ask ADVFN Intelligence (AI)

GE9 Latest News

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

Genmab Announces Initiation of Share Buy-Back Program

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

GE9 - Frequently Asked Questions (FAQ)

Movers

GE9 Financials

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free